Treatment of Hirsutism in Women with Obesity and Polycystic Ovary Syndrome

Hirsutism presenting alongside obesity and polycystic ovary syndrome (PCOS) represents a clinically distinct scenario that influences the selection and sequencing of first-line management strategies.

Clinical Scenario

This protocol applies to hirsute women with the following concurrent conditions:

Obesity Polycystic Ovary Syndrome (PCOS)

In this population, guidelines specifically recommend addressing obesity as part of the management plan, alongside pharmacological approaches.

Treatment Approach (partial overview)

First-line management in this setting incorporates lifestyle modification alongside initial pharmacological therapy. The full structured regimen — including the specific sequence, pharmacological agents, and individualized targets — is available via the protocol below.

Clinical Goal

Treatment success is assessed by improvement in hirsutism, measurable as a reduction in the Ferriman–Gallwey hirsutism score.

Instant Access to Structured Evidence-Based Regimens